AI-Powered Clinical Trial Analytics & Risk Detection

CluePoints utilizes central statistical monitoring and AI to help users uncover nuances missed by traditional data quality control methods, empowering focused analysis on only the most pertinent data points. With CluePoints’ advanced analytics, you can navigate clinical trials with greater efficiency and confidence.


Key Risk Indicators (KRIs)

By harnessing statistical algorithms and subjective thresholds, our KRI dashboard ranks sites based on performance metrics, spotlighting ‘at-risk’ locations. Users can select from pre-defined KRIs or adapt indicators to trial data, which yields scores that benchmark site performance against peers and tolerance limits, pinpointing causation and ensuring proactive corrective actions through an integrated issue-tracking management system.

  • Measure non-serious adverse events per patient visit for safety monitoring
  • Track serious adverse events per patient visit for safety assessment
  • Indicate missed patient assessments compared to expected
  • Monitor deviations from study protocol per patient visit for adherence
  • Measure patient visits conducted outside allowable schedules
  • Calculate the average time from patient visit to eCRF entry
  • Determine the rate of auto-queries per data point submitted
  • Evaluate the average time from query generation to response
  • Assess the proportion of screen-failed patients to the total screened
  • Measure the rate of early-terminated patients per visit
Play Video

Quality Tolerance Limits (QTLs)

Our QTL module automatically identifies systematic issues, monitors key metrics, and documents deviations from pre-defined QTLs. Our platform automatically uncovers threats to trial validity and patient safety, enabling early detection and corrective action. With comprehensive documentation of QTLs and breaches, including justification and evidence, all in one accessible platform, teams can ensure accountability and compliance throughout trials.

  • Monitor the rate of patients discontinuing study drug treatment prematurely
  • Monitor the rate of enrolled patients lost to follow-up
  • Monitor the rate of patients terminating participation before reaching an endpoint milestone
Play Video

Central Statistical Monitoring

Central Statistical Monitoring enables users to test all collected data, including both clinical and operational, spotlighting patients, sites, and countries exhibiting atypical data patterns and uncovering operational challenges that may otherwise remain hidden. Central Statistical Monitoring lets you review trends in results, delve into underlying data, and manage findings within a unified issue management environment.

  • Identify any instances of fraudulent activity or inaccuracies associated with patient information
  • Identify errors in data recording, including improper rounding or digit manipulation
  • Identify widespread errors stemming from equipment malfunctions or other systemic issues
  • Identify any biases or deficiencies in the training of raters or assessors
  • Identify data timeliness issues, such as implausible data accrual rates
Play Video

Duplicate Patients

Our platform preemptively identifies professional patients within trials to prevent enrollment abuse. Duplicate Patients generates a priority listing of patient pairs by specifying configurable variables—such as age, sex, height, weight, country, and race—likely to indicate duplicates. Users can review automated results within a convenient interface, prioritizing based on similarity scores and comparing side-by-side records for quick evaluation.

  • Address challenges posed by site proximity, particularly in regions like North America where states such as California, Florida, Pennsylvania, and New York serve as hubs for research sites
Play Video

Patient Profiles

The seamless integration of Central Statistical Monitoring with our Patient Profiles module enables clinical teams to identify atypical patient patterns and prioritize investigations into anomalies within data sets, ranking patients based on their degree of atypicality. Users can gain detailed insights into patient experiences and leverage user-friendly data visualizations to target those of utmost importance.

  • Characterize risk signals quickly and effectively, enabling centralized medical and safety reviews
  • Assess chronological views of patients’ visits, investigational product exposure, adverse events, concomitant medications, and other pertinent patient information
Play Video

Business Intelligence (BI)

BEYOND is an advanced data visualization solution that goes beyond traditional statistical analysis, enabling users to explore clinical and operational data from various perspectives and in customizable formats. With multiple data widgets and combined data from different domains, users can summarize and aggregate data effectively and focus on specific aspects of trial operations, facilitating the identification of emerging risks and operational challenges.

  • Focus on safety-related data, allowing for top-down analysis of adverse event distribution
  • Examine outliers, identify associated adverse events and medications, and make comparisons over time
  • Integrate forecast data for further insights into predicted versus actual enrollment and screen failure rates
  • Extend the view to compute averages across sites for a thorough assessment of operational metrics
Play Video

On-Demand Demos

Dive into the full potential of CluePoints’ AI-powered RBQM solutions right from the comfort of your screen.

See It in Action

Request a Personalized Demo